Reference number : 236-2011-2012-Q4-00696, amendment number : , agreement type : G, recipient legal name : TANNOCK, Ian F, recipient country : CA, recipient province : ON, recipient city : Toronto, recipient postal code : M5G 2C4, program name english : nan, program name french : nan, program purpose english : nan, program purpose french : nan, agreement title english : nan, agreement title french : nan, agreement number : nan, agreement value : 297244.0, agreement start date : 2012-04-01, agreement end date : 2015-03-31, description english : Phase II clinical trial of pantoprazole and docetaxel for men with metastatic castration-resistant prostate cancer, description french : Phase II clinical trial of pantoprazole and docetaxel for men with metastatic castration-resistant prostate cancer, expected results english : nan, expected results french : nan, additional information english : Grant or Award spanning more than one fiscal year.
(2012-13 to 2014-15), additional information french : Subvention ou bourse octroyée s'appliquant à plus d'un exercice financier.
(2012-13 à 2014-15), owner organization : cihr-irsc, owner organization title : Canadian Institutes of Health Research | Instituts de recherche en santé du Canada